CLINICAL_TRIALS
trial_result
· 2007-10-16
Clinical Trial Update: Mefloquine Bioequivalence Among 3 Commercially Available Tablets.
Summary
This completed study evaluated the bioequivalence of three commercially available mefloquine tablet formulations for malaria prevention.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Centers for Disease Control and Prevention | Conditions: Malaria | Status: COMPLETED